BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 35972597)

  • 1. Differential molecular mechanistic behavior of HDACs in cancer progression.
    Singh T; Kaur P; Singh P; Singh S; Munshi A
    Med Oncol; 2022 Aug; 39(11):171. PubMed ID: 35972597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.
    Ramaiah MJ; Tangutur AD; Manyam RR
    Life Sci; 2021 Jul; 277():119504. PubMed ID: 33872660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Histone Modifications in Bone and Lung Metastatic Cancers.
    Edwards CM; Johnson RW
    Curr Osteoporos Rep; 2021 Jun; 19(3):230-246. PubMed ID: 33721181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research advance on mechanism and application of HATs and HDACs in epithelial-mesenchymal transition of lung cancer].
    Chang R; You J; Zhou Q
    Zhongguo Fei Ai Za Zhi; 2013 Apr; 16(4):211-5. PubMed ID: 23601302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.
    Li Z; Zhu WG
    Int J Biol Sci; 2014; 10(7):757-70. PubMed ID: 25013383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of histone deacetylases (HDACs) in UPR regulation.
    Kahali S; Sarcar B; Chinnaiyan P
    Methods Enzymol; 2011; 490():159-74. PubMed ID: 21266250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes.
    Wang Z; Zang C; Cui K; Schones DE; Barski A; Peng W; Zhao K
    Cell; 2009 Sep; 138(5):1019-31. PubMed ID: 19698979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.
    Kedhari Sundaram M; Hussain A; Haque S; Raina R; Afroze N
    J Cell Biochem; 2019 Oct; 120(10):18357-18369. PubMed ID: 31172592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases.
    Gatla HR; Muniraj N; Thevkar P; Yavvari S; Sukhavasi S; Makena MR
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30841513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum.
    Kanyal A; Rawat M; Gurung P; Choubey D; Anamika K; Karmodiya K
    FEBS J; 2018 May; 285(10):1767-1782. PubMed ID: 29284196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
    Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
    Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of histone deacetylases (HDACs) in human cancer.
    Ropero S; Esteller M
    Mol Oncol; 2007 Jun; 1(1):19-25. PubMed ID: 19383284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
    Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
    Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deacetylation of Transcription Factors in Carcinogenesis.
    Halasa M; Adamczuk K; Adamczuk G; Afshan S; Stepulak A; Cybulski M; Wawruszak A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in histone deacetylase targeted cancer therapy.
    Hoshino I; Matsubara H
    Surg Today; 2010 Sep; 40(9):809-15. PubMed ID: 20740342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging roles of HDACs and their therapeutic implications in cancer.
    Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
    Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Zebularine in Comparison to and in Combination with Trichostatin A on CIP/KIP Family (p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2), DNMTs (DNMT1, DNMT3a, and DNMT3b), Class I HDACs (HDACs 1, 2, 3) and Class II HDACs (HDACs 4, 5, 6) Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer LS 174T Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2131-2139. PubMed ID: 32711442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy.
    Patra S; Panigrahi DP; Praharaj PP; Bhol CS; Mahapatra KK; Mishra SR; Behera BP; Jena M; Bhutia SK
    Cell Mol Life Sci; 2019 Sep; 76(17):3263-3282. PubMed ID: 30982077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.